Area of research
Toxicology · Pharmacology
Research interest
Research interests include Medicine, Synthetic cannabinoids, Chemistry, Pharmacology, Forensic toxicology, and Designer drug.
Establishing new boundaries for medical liability: The role of AI as a decision-maker
Ethanol enhances JWH-018-induced impairment of sensorimotor and memory functions in mice: From preclinical evidence to forensic implication in Driving Under the Influence of Drugs
Gender differences in driving under the influence of psychoactive drugs: Evidence mapping of real case studies and meta-analysis
Sensorimotor Alterations Induced by Novel Fentanyl Analogs in Mice:Possible Impact on Human Driving Performances
Atrophic pseudarthrosis of humeral diaphyseal fractures: medico-legal implications and methodological analysis of the evaluation.
Hair determination of per- and polyfluoroalkyl substances (PFAS) in the Italian population
Development and validation of a rapid LC‐MS/MS method for the detection of 182 novel psychoactive substances in whole blood
Molecular Mechanisms of Action of Novel Psychoactive Substances (NPS). A New Threat for Young Drug Users with Forensic-Toxicological Implications
Importance of dashboard camera (Dash Cam) analysis in fatal vehicle–pedestrian crash reconstruction
Post-Mortem Toxicology: A Systematic Review of Death Cases Involving Synthetic Cannabinoid Receptor Agonists
Homicide and concealment of the corpse. Autopsy case series and review of the literature
The Novel Psychoactive Substance Cumyl-CH-MEGACLONE: Human Phase-I Metabolism, Basic Pharmacological Characterization and Comparison to Other Synthetic Cannabinoid Receptor Agonists with a γ-Carboline-1-One Core
Application of aquatic decomposition scores for the determination of the Post Mortem Submersion Interval on human bodies recovered from the Northern Adriatic Sea
Detection of the recently emerged synthetic cannabinoid 4F‐MDMB‐BINACA in “legal high” products and human urine specimens
Radiological investigation of gunshot wounds: a systematic review of published evidence
Four cases of death involving the novel synthetic cannabinoid 5F-Cumyl-PEGACLONE